Ho JJ, Crawley S, Pan PL, Farrelly ER, Kim YS
GLP-1 receptor agonist medications mimic and amplify this hormones effects, binding to receptors throughout the brain, gut, and pancreas
To get there, we need to systematically study smaller doses of real GLP-1 therapies in people with different conditions
Peptide Therapy at a Glance EXPECTED RESULTS Enhanced cellular repair, improved hormone balance, increased energy, better sleep, fat loss, and immune support TREATMENT LENGTH Varies daily or weekly administration over 412+ weeks depending on protocol RECOMMENDED SESSIONS Ongoing use for 13 months, with regular monitoring and dose adjustments WHERE IT TREATS Systemic works at the cellular level to support immune, endocrine, metabolic, and neurological systems WHAT IT TREATS Hormone imbalance, weight gain, poor recovery, fatigue, inflammation, aging, low libido, immune dysfunction, and neurological decline TREATMENT COST $350 $1,200/month (depending on the type of peptide and dosing protocol) What is Peptide Therapy
In 2021, UK HealthCare determined that its CLABSI rates were higher than similar academic medical centers
However, recent years have witnessed a mounting body of research on the effects of GLP-1 analogs, demonstrating the systemic effects of GLP-1 which extend beyond the incretin effect and affect diverse organ systems (see Figure 1)
